Your browser doesn't support javascript.
loading
Safety of BNT162b2 mRNA COVID-19 vaccine in a cohort of elderly, immunocompromised patients with systemic vasculitis.
Delvino, Paolo; Bozzalla-Cassione, Emanuele; Biglia, Alessandro; Quadrelli, Verdiana Serena; Bartoletti, Alice; Montecucco, Carlomaurizio; Monti, Sara.
Affiliation
  • Delvino P; Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, and PhD in Experimental Medicine, University of Pavia, Italy. paolo.delvino01@universitadipavia.it.
  • Bozzalla-Cassione E; Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
  • Biglia A; Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
  • Quadrelli VS; Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
  • Bartoletti A; Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
  • Montecucco C; Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
  • Monti S; Rheumatology Department, IRCCS Policlinico S. Matteo Foundation, University of Pavia, Italy.
Clin Exp Rheumatol ; 40(4): 853, 2022 05.
Article in En | MEDLINE | ID: mdl-34528506

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD Database: MEDLINE Main subject: Systemic Vasculitis / COVID-19 / BNT162 Vaccine Limits: Aged / Humans Language: En Journal: Clin Exp Rheumatol Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD Database: MEDLINE Main subject: Systemic Vasculitis / COVID-19 / BNT162 Vaccine Limits: Aged / Humans Language: En Journal: Clin Exp Rheumatol Year: 2022 Document type: Article